Blog: You, us, everyone

Welcome to our blog – a place to discuss and exchange thoughts and ideas about iX-7 Asset Management SA, the stock markets and all matters relating to wealth management.


Article
Monday, July 22, 2013 by Christoph.Schmid|Comment 0
within category ROG,Biologics,US Medicare reform,Biotechnology,Healthcare services,HealthCare - Education - IT,Swiss premium selection,All-Star selection

Company profile, investment opportunity and asset management integration:

Metric Rating
Operational risks: Average
Expected growth: Well above average
Long term value creation: Outstanding
Positive competitive advantage: Excellent
Management excellence: Positive
Financial strength: Well above average
Investment orientation: Group Best-in-Class:

Healthcare services, Healthcare,
Education and IT, All-Star Selection, 
Swiss Premium Selection.


Comments
Not commented yet? Be the first to post a comment.
Current pageTotal pages 0
Comments per page
select
Add a comment
Author:
Email: Help
Related articles
Friday, August 2, 2013
Description: Pfizer is the world's largest branded pharmaceutical company. Annual sales reach a volume of USD 60 billion. Pfizer maintains a broad portfolio of medicines which includes treatments fo…
More …

Monday, July 22, 2013
Description: Roche, based in Basel, Switzerland, operates in two segments: Pharmaceuticals and Diagnostics. In the area of biotechnology, it’s the world leader. The company’s major products are: A…
More …

Wednesday, July 10, 2013
Description: Medtronic is a leading developer, manufacturer and marketer of medical devices (therapeutic and diagnostic). Founded in 1949, Medtronic is now the world’s largest medical technology…
More …
iX-7 Asset Management SA, access to financial information is a right. Knowledge is power.